NEXENTIS TECHNOLOGIES INC
NXTSNASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- $1.55 β $119.00
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 2.4M
- Next Earnings
- 2027-03-03
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- β
- P/S Ratio
- 4.5x
- EPS (TTM)
- $-205.17
- Dividend Yield
- β
- Dilution (1yr)
- +764.3%
NEXENTIS TECHNOLOGIES INC
NXTSAbout NEXENTIS TECHNOLOGIES INC
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.